{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04655",
    "Peptide Name": "LS-AMP-F1 (Lys-rich; natural AMPs; Spiders, arachnids, Chelicerata, arthropods, invertebrates, animals, UCLL1)",
    "Source": "the Chinese Wolf Spider,Lycosa sinensis",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "TGLGKIGYLMKKLLSKAKV",
    "Sequence Length": 19,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Synergistic AMPs",
      "Antibiofilm"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 5,
    "Boman Index": -0.09,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "42%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (52.63%) toLC-AMP-F1K: 26%, G: 16%, L: 21%. GRAVY: 0.216; Mol Wt: 2048.591; mol formula: C95H170N24O23S1; mol ex coeff: 1490.Activity:  active against Gram- S. typhimurium CGMCC1.1174 (MIC 12.5 uM), E. coli  CCTCC AB 2012883 and 10 clinical strains (MIC 12.5-50 uM), P. aeruginosa 4 clinical strains (MIC 25->50), A. baumannii 6 clinical strains (MIC 3.1-25 uM), S. dysenteriae CGMCC 1.1869 (MIC 25 uM), P-vulgaris CGMCC 1.1651 (MIC >50 uM), Gram+ E. faecium 2 clinical strains (MIC 12.5 uM), S. albus CGMCC 1.3374 (MIC 6.25 uM), S. aureus  4 clincial strains (MIC 25-100 uM), and S. citreus CCTCC AB 91115 (MIC 6.25 uM). Inhibit the formation of biofilms:bacteria:E. coli.Synergy:antibiotics:   Synergy with Azithromycin, Erythromycin, and Doxycycline against E. coli or S. albus.",
    "Author": "Tan H, Wang J, Song Y, Liu S, Lu Z, Luo H, Tang X.2022",
    "Reference": "Pharmaceutics. 2022 Nov 21;14(11):2540. doi: 10.3390/pharmaceutics14112540.PubMed",
    "Title": "Antibacterial Potential Analysis of Novel alpha-Helix Peptides in the Chinese Wolf Spider Lycosa sinensis."
  },
  "3D Structure": []
}